Quarterly Recap of Pharmacy Faculty Research Grants – FY2020 Q2 and Q3

Close up look at a section of the UConn School of Pharmacy Building

Recapping the quarters beginning October 1, 2019 through March 31, 2020, the UConn School of Pharmacy congratulates the following Department of Pharmaceutical Sciences and Pharmacy Practice faculty and their teams for their research grant awards* totaling $6,002,715 :

Department of Pharmaceutical Sciences:

Robin H. Bogner, Ph.D.
MedImmune
Identifying the Causes for Long Reconstitution Times: Phase III. Exploring the effect of freezing protocol on the porous structure and Tg’ of lyophilized formulations
10/08/2019 $400,000

Xiuling Lu, Ph.D.
DHHS/NIH/National Cancer Institute/NAMI Therapeutics
Nanoparticle-Based Intraperitoneal Delivery of Combined Chemo-Brachytherapy Corp for Treatment of Ovarian Cancer Metastases
12/03/2019 $135,643

Xiuling Lu, Ph.D.
DHHS/NIH/National Institute on Drug Abuse/Virginia Commonwealth
Novel LAAM Formulations to Treat Opioid Use Disorder
12/04/2019 $443,068

Diane J. Burgess, Ph.D.
DHHS/FDA/Food and Drug Administration/DigiM
Microstructure characterization with micro-imaging and image-based analytics: a Solution new tool to characterize complex polymer-based long acting drug products
12/06/2019 $210,001

Raman Bahal, Ph.D.
DHHS/NIH/National Heart, Lung, and Blood Institute
Developing next generation synthetic nucleic acid analogous for sickle cell disease
12/09/2019 $2,000,300

Diane J. Burgess, Ph.D.
W. L. Gore & Associates
Investigation of Obstruction of Catheters Used for Intraperitoneal Insulin Delivery
01/20/2020 $214,500

Brian J. Aneskievich, Ph.D.
DOD/Department of Defense
Cytoplasmic Suppression of Inflammatory Signaling
01/22/2020 $322,000

Matthew Kyle Hadden, Ph.D.
DHHS/NIH/National Cancer Institute/University of Massachusetts Medical School
Targeting replication stress avoidance in cancer
03/07/2020 $75,438

Dennis Wright, Ph.D.
DHHS/NIH/National Institute of Allergy and Infectious Diseases/University of Connecticut Health Center Genetics of HSV DNA Replication
03/13/2020 $1,028,525

Diane J. Burgess, Ph.D.
DHHS/FDA/Food and Drug Administration
Impact of Polymer Attributes on the Performance of In Situ Forming Implants
03/24/2020 $973,184

Department of Pharmacy Practice:

Craig Coleman, Pharm.D.
Portola Pharmaceuticals/Hartford Hospital Comparative Effectiveness and Safety of Andexanet Alfa and Four-Factor Prothrombin Eomplex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Intracranial Hemorrhage: A Pilot Study
12/04/2019 $138,022

Nathaniel M. Rickles, Pharm.D., Ph.D.
DHHS/SAMHSA/Substance Abuse and Mental Health Academic Detailing on Opioid Safety in CT Services Administration/CT Department of Mental Health and Addiction Services
12/19/2019 $62,034

* Grant awards listed in the OVPR Quarterly Reports are those reported as fully executed.